John E. Edwards

42.9k total citations · 12 hit papers
229 papers, 27.0k citations indexed

About

John E. Edwards is a scholar working on Infectious Diseases, Epidemiology and Oncology. According to data from OpenAlex, John E. Edwards has authored 229 papers receiving a total of 27.0k indexed citations (citations by other indexed papers that have themselves been cited), including 131 papers in Infectious Diseases, 94 papers in Epidemiology and 24 papers in Oncology. Recurrent topics in John E. Edwards's work include Antifungal resistance and susceptibility (124 papers), Fungal Infections and Studies (77 papers) and Parasitic Diseases Research and Treatment (17 papers). John E. Edwards is often cited by papers focused on Antifungal resistance and susceptibility (124 papers), Fungal Infections and Studies (77 papers) and Parasitic Diseases Research and Treatment (17 papers). John E. Edwards collaborates with scholars based in United States, British Virgin Islands and United Kingdom. John E. Edwards's co-authors include Brad Spellberg, Ashraf S. Ibrahim, Scott G. Filler, John S. Bradley, David N. Gilbert, George H. Talbot, Helen W. Boucher, Michael Scheld, John Rex and Peter G. Pappas and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

John E. Edwards

215 papers receiving 25.8k citations

Hit Papers

Bad Bugs, No Drugs: No ESKAPE! An Update from th... 1994 2026 2004 2015 2008 2009 2007 2004 2005 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
    2008 3.9k citations John E. Edwards, Brad Spellberg et al. Clinical Infectious Diseases profile →
  2. Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
    2009 2.3k citations Peter G. Pappas, Carol A. Kauffman et al. Clinical Infectious Diseases profile →
  3. The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America
    2007 1.3k citations Brad Spellberg, John E. Edwards et al. Clinical Infectious Diseases profile →
  4. Guidelines for Treatment of Candidiasis
    2004 1.0k citations Peter G. Pappas, John Rex et al. Clinical Infectious Diseases profile →
  5. Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and Management
    2005 991 citations Brad Spellberg, John E. Edwards et al. profile →
  6. Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America
    2006 846 citations John E. Edwards et al. Clinical Infectious Diseases profile →
  7. A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia
    1994 786 citations John Rex, John E. Bennett et al. profile →
  8. Practice Guidelines for the Treatment of Candidiasis
    2000 694 citations John Rex, Thomas J. Walsh et al. Clinical Infectious Diseases profile →
  9. Type 1/Type 2 Immunity in Infectious Diseases
    2001 673 citations Brad Spellberg, John E. Edwards Clinical Infectious Diseases profile →
  10. A Prospective Observational Study of Candidemia: Epidemiology, Therapy, and Influences on Mortality in Hospitalized Adult and Pediatric Patients
    2003 666 citations Peter G. Pappas, John Rex et al. Clinical Infectious Diseases profile →
  11. Trends in Antimicrobial Drug Development: Implications for the Future
    2004 633 citations Brad Spellberg, John E. Edwards et al. Clinical Infectious Diseases profile →
  12. 1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever
    1997 503 citations John E. Edwards et al. Clinical Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John E. Edwards United States 66 16.5k 12.6k 4.5k 3.4k 2.8k 229 27.0k
Po‐Ren Hsueh Taiwan 86 15.5k 0.9× 12.8k 1.0× 5.5k 1.2× 8.8k 2.6× 3.3k 1.2× 970 38.6k
Daniel J. Diekema United States 90 22.7k 1.4× 17.1k 1.4× 3.9k 0.9× 2.0k 0.6× 2.6k 0.9× 352 30.6k
Allison McGeer Canada 91 13.3k 0.8× 13.0k 1.0× 2.6k 0.6× 2.2k 0.7× 1.4k 0.5× 581 30.4k
John G. Bartlett United States 91 16.2k 1.0× 20.5k 1.6× 7.0k 1.6× 4.1k 1.2× 3.5k 1.2× 404 45.8k
David R. Andes United States 90 21.1k 1.3× 15.6k 1.2× 5.8k 1.3× 2.7k 0.8× 6.4k 2.3× 350 30.5k
Vance G. Fowler United States 82 16.2k 1.0× 14.9k 1.2× 5.6k 1.3× 3.0k 0.9× 2.4k 0.8× 400 31.3k
Brad Spellberg United States 67 9.6k 0.6× 7.1k 0.6× 4.5k 1.0× 5.3k 1.6× 2.6k 0.9× 216 21.6k
Eleftherios Mylonakis United States 79 9.3k 0.6× 7.7k 0.6× 5.4k 1.2× 1.8k 0.5× 1.3k 0.5× 430 22.5k
Robin Patel United States 86 9.2k 0.6× 10.0k 0.8× 5.4k 1.2× 2.4k 0.7× 1.2k 0.4× 645 30.0k
Barbara E. Murray United States 79 19.6k 1.2× 7.6k 0.6× 9.5k 2.1× 6.9k 2.0× 3.3k 1.2× 334 35.4k

Countries citing papers authored by John E. Edwards

Since Specialization
Citations

This map shows the geographic impact of John E. Edwards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Edwards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Edwards more than expected).

Fields of papers citing papers by John E. Edwards

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John E. Edwards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Edwards. The network helps show where John E. Edwards may publish in the future.

Co-authorship network of co-authors of John E. Edwards

This figure shows the co-authorship network connecting the top 25 collaborators of John E. Edwards. A scholar is included among the top collaborators of John E. Edwards based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John E. Edwards. John E. Edwards is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alqarihi, Abdullah, Teclegiorgis Gebremariam, Yiyou Gu, et al.. (2020). GRP78 and Integrins Play Different Roles in Host Cell Invasion during Mucormycosis. mBio. 11(3). 72 indexed citations
2.
Liu, Yaoping, Norma V. Solis, Ling Wang, et al.. (2020). Identification of Candida glabrata Transcriptional Regulators That Govern Stress Resistance and Virulence. Infection and Immunity. 89(3). 11 indexed citations
3.
Uppuluri, Priya, Lin Lin, Abdullah Alqarihi, et al.. (2018). The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection. PLoS Pathogens. 14(5). e1007056–e1007056. 39 indexed citations
4.
Chan, Liana C., Scott G. Filler, Huiyuan Wang, et al.. (2015). Nonredundant Roles of Interleukin-17A (IL-17A) and IL-22 in Murine Host Defense against Cutaneous and Hematogenous Infection Due to Methicillin-Resistant Staphylococcus aureus. Infection and Immunity. 83(11). 4427–4437. 44 indexed citations
5.
Pappas, Peter G., Carol A. Kauffman, David R. Andes, et al.. (2009). Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases. 48(5). 503–535. 2325 indexed citations breakdown →
6.
Spellberg, Brad, Ashraf S. Ibrahim, Michael R. Yeaman, et al.. (2008). The Antifungal Vaccine Derived from the Recombinant N Terminus of Als3p Protects Mice against the Bacterium Staphylococcus aureus. Infection and Immunity. 76(10). 4574–4580. 123 indexed citations
7.
Ibrahim, Ashraf S., Teclegiorgis Gebremariam, Julie Schwartz, John E. Edwards, & Brad Spellberg. (2008). Posaconazole Mono- or Combination Therapy for Treatment of Murine Zygomycosis. Antimicrobial Agents and Chemotherapy. 53(2). 772–775. 83 indexed citations
8.
Phan, Quynh T., Carter L. Myers, Yue Fu, et al.. (2007). Als3 Is a Candida albicans Invasin That Binds to Cadherins and Induces Endocytosis by Host Cells. PLoS Biology. 5(3). e64–e64. 464 indexed citations
9.
Klotz, Stephen A., Nand K. Gaur, Donald C. Sheppard, et al.. (2007). Candida albicansAls proteins mediate aggregation with bacteria and yeasts. Medical Mycology. 45(4). 363–370. 94 indexed citations
10.
Ibrahim, Ashraf S., Brad Spellberg, Valentina Avanesian, Yue Fu, & John E. Edwards. (2006). The Anti- Candida Vaccine Based on the Recombinant N-Terminal Domain of Als1p Is Broadly Active against Disseminated Candidiasis. Infection and Immunity. 74(5). 3039–3041. 58 indexed citations
11.
Spellberg, Brad, Ashraf S. Ibrahim, John E. Edwards, & Scott G. Filler. (2005). Mice with Disseminated Candidiasis Die of Progressive Sepsis. The Journal of Infectious Diseases. 192(2). 336–343. 185 indexed citations
12.
Ibrahim, Ashraf S., et al.. (2004). Cdc42p GTPase Regulates the Budded-to-Hyphal-Form Transition and Expression of Hypha-Specific Transcripts in Candida albicans. Eukaryotic Cell. 3(3). 724–734. 34 indexed citations
13.
Rex, John, Thomas J. Walsh, J. D. Sobel, et al.. (2000). Practice Guidelines for the Treatment of Candidiasis. Clinical Infectious Diseases. 30(4). 662–678. 694 indexed citations breakdown →
14.
Walker, Michael, James Schumacher, David G. Schmitz, et al.. (1998). Cobalt 60 radiotherapy for treatment of squamous cell carcinoma of the nasal cavity and paranasal sinuses in three horses. Journal of the American Veterinary Medical Association. 212(6). 848–851. 26 indexed citations
15.
16.
Rex, John, John E. Bennett, Alan M. Sugar, et al.. (1995). Intravascular Catheter Exchange and Duration of Candidemia. Clinical Infectious Diseases. 21(4). 994–996. 181 indexed citations
17.
Witt, Mallory D., et al.. (1995). Acute Invasive Rhinocerebral Zygomycosis in an Otherwise Healthy Patient: Case Report and Review. Clinical Infectious Diseases. 20(1). 163–166. 77 indexed citations
18.
Edwards, John E.. (1985). The "Conversos": A Theological Approach. Bulletin of Hispanic Studies. 62(1). 39–39. 2 indexed citations
19.
Edwards, John E. & Wallace Wilkins. (1981). Verbalizer-Visualizer Questionnaire: Relationship with imagery and verbal–visual ability.. 16 indexed citations
20.
Edwards, John E.. (1952). Simple Fundus Camera. American Journal of Ophthalmology. 35(6). 851–855. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Po‐Ren Hsueh Breakdown of academic impact, for papers by Daniel J. Diekema Breakdown of academic impact, for papers by Allison McGeer Breakdown of academic impact, for papers by John G. Bartlett Breakdown of academic impact, for papers by David R. Andes Breakdown of academic impact, for papers by Vance G. Fowler Breakdown of academic impact, for papers by Brad Spellberg Breakdown of academic impact, for papers by Eleftherios Mylonakis Breakdown of academic impact, for papers by Robin Patel Breakdown of academic impact, for papers by Barbara E. Murray
Rankless by CCL
2026